We also observed that c-MYC, a key CSC regulatory protein and transcriptional factor implicated in promoting tumor growth and cancer stemness, is markedly reduced in SUM159-shXIST but not SCR cells following DOX treatment (Fig. 6A). The gene discussed is MYC; the disease is cancer.